Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Andelyn Biosciences uses AAV curator platform to deliver novel gene therapy for ultra-rare NEDAMSS…
The platform allows for the ability to support the exacting viral vector manufacturing needs of different types of patients
Trump calls for drug price cuts, order aims to reduce prices by 30-80 per cent
The order gives drugmakers price targets in the next 30 days, and will take further action to lower prices if those companies do…
Agilent inaugurates India Solution Center to accelerate innovation and expand the frontiers of…
Integrated facility aims to deliver end-to-end, customised workflows across lifesciences, diagnostics, and applied markets
Accretion Pharmaceuticals’ IPO to open on May 14 2025; Price band fixed at ₹96-101
The company aims to utilise the funds towards purchasing new equipment, upgrading the manufacturing plant and repayment of certain…
HIV market to exceed $32 bn across 7MM in 2033, forecasts GlobalData
Market growth will primarily be driven by the increased uptake of long-acting injectable therapies, as well as the anticipated…
Coliform bacteria and E. coli in pharma water systems: A hidden threat to product integrity
Water quality is critical in pharma manufacturing, and contamination by coliforms or E. coli can threaten product safety and…
Pharma CRDMO revenue forecasts 13-15 per cent growth amid supply-chain derisking
Resultant strong cash flows will enable Indian CRDMOs to continue capital expenditure (capex), with limited reliance on debt…
Enterprise Risk Management (ERM): A critical imperative for India’s pharma sector
Gurmeet Singh, Procurement Director, Alfa Pharma, highlights how risk-resilient practices can strengthen the Indian pharma…
We are well-aligned to capitalise on the CDMO opportunity
Dr Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions (LMS), explains to Viveka Roychowdhury how LMS is aligning long-term…
Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg
Being the exclusive first-to-file, Lupin is eligible for 180-day generic exclusivity